Symptoms of hypoglycaemia including dizziness, confusion, and sweating may be mistaken for intoxication, delaying appropriate treatment
They mimic a hormone called GLP-1, which helps the pancreas produce insulin
The degradation products of semaglutide are not known to cause dangerous adverse reactions beyond potential injection site reactions from aggregated particles
If you experience persistent pain, significant bruising, or signs of infection (redness, warmth, swelling, discharge), contact your GP promptly
Monthly check-ins Every 4 weeks, assess whether your current frequency and dose are optimal
Why Two Pathways Matter By targeting both receptor types, tirzepatide provides a more comprehensive metabolic effect than medications that function solely as GLP-1 receptor agonists